Recalls & Warnings November 21, 2013 FDA Warns of Five More Weight Loss Supplements Containing Undeclared Drugs On November 21, 2013, the FDA warned consumers not to buy or use the following weight loss supplements because they were found to contain one or both of the undeclared drugs sibutramine and phenolphthalein: Recalls & Warnings December 12, 2014 Marketers of HCG Settle FTC Charges of Deceptive Weight Loss Claims Marketers of HCG Platinum drops have agreed to pay $1 million to settle Federal Trade Commission (FTC) charges that claims the drops could cause rapid and substantial weight loss were deceptive and not supported by scientific evidence
The reduction in vascular oxidative stress is a key step in alleviating the heavy, aching limbs and cognitive dysfunction that plague so many patients
By blocking this enzyme, sitagliptin increases incretin levels, which in turn stimulate insulin release from the pancreas in a glucose-dependent manner and reduce glucagon secretion
[DOI] [PubMed] [Google Scholar] 39.Shah S., Page C.P., Spina D
The dual action creates stronger effects on the digestive system, leading to somewhat higher rates of gastrointestinal side effects